Plasmonic photothermal therapy for atheroregression below Glagov threshold

Area of Science:

• Cardiovascular Research
• Nanomedicine
• Biomedical Engineering

Background:

• Atherosclerosis involves plaque buildup, challenging vascular remodeling.
• Nanomedicine provides novel diagnostic and therapeutic tools.
• Clinical applications of nanomedicine in cardiology are emerging.

Purpose of the Study:

• To review nanomedicine advancements in interventional cardiology.
• To focus on achieving atheroregression below the Glagov threshold (40%).
• To highlight plasmonic photothermal therapy for atherosclerosis reversal.

Main Methods:

• Review of current nanomedicine technologies for atherosclerosis.
• Analysis of vascular remodeling and plaque burden thresholds.
• Focus on plasmonic photothermal therapy mechanisms.

Main Results:

• Nanomedicine enables precise diagnosis and targeted atherosclerosis treatment.
• Plasmonic photothermal therapy shows promise for atheroregression.
• The Glagov threshold (40%) is identified as a key target for intervention.

Conclusions:

• Nanomedicine holds significant potential for clinical application in cardiology.
• Targeting the plaque burden threshold is crucial for reversing atherosclerosis.
• Further development of nanomedicine tools is essential for effective atheroregression.